On the other hand, because blockage of ADMsignaling suppresses tumor xenograft growth and metastasis in animals [26, 29, 43, 47, 49, 57], ADM antagonists are being developed asanti-tumor/angiogenesis therapy [26, 29, 43, 47, 49, 57, 58]. The gene discussed is ADM; the disease is neoplasm.